PTC
GMAB icon

Private Trust Company’s Genmab GMAB Stock Holding History

Private Trust Company’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-323
Closed -$9.95K – 2643
2025
Q4 		$9.95K Hold
323
– – ﹤0.01% 1936
2025
Q3 		$9.91K Buy
323
+315
+3,938% +$7.68K ﹤0.01% 1910
2025
Q2 		$165 Hold
8
– – ﹤0.01% 2441
2025
Q1 		$157 Sell
8
-121
-94% -$2.54K ﹤0.01% 2455
2024
Q4 		$2.69K Sell
129
-571
-82% -$12.5K ﹤0.01% 2135
2024
Q3 		$17.1K Buy
700
+120
+21% +$3.21K ﹤0.01% 1528
2024
Q2 		$14.6K Buy
580
+15
+3% +$425 ﹤0.01% 1557
2024
Q1 		$16.9K Buy
565
+101
+22% +$2.97K ﹤0.01% 1492
2023
Q4 		$14.8K Hold
464
– – ﹤0.01% 1516
2023
Q3 		$16.4K Buy
464
+10
+2% +$381 ﹤0.01% 1426
2023
Q2 		$17.3K Sell
454
-47
-9% -$1.87K ﹤0.01% 1419
2023
Q1 		$18.9K Sell
501
-365
-42% -$14K ﹤0.01% 1355
2022
Q4 		$37K Buy
866
+76
+10% +$3.13K 0.01% 1062
2022
Q3 		$25K Buy
790
+141
+22% +$4.95K ﹤0.01% 1122
2022
Q2 		$21K Buy
+649
New +$21K ﹤0.01% 1219

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $10.6B AUM 19.39% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Private Trust Company's GMAB Position: Q1 2026 in Review

Private Trust Company sold out of Genmab (GMAB) in Q1 2026, closing a stake of 323 shares — an estimated $9.95K sold.

Private Trust Company first reported a position in GMAB in Q2 2022 and held it in 15 quarters. The position peaked at $37K in Q4 2022. 275 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • Private Trust Company reported no remaining Genmab position as of Q1 2026 after selling out during the quarter.
  • Private Trust Company sold 323 Genmab shares in Q1 2026, an estimated $9.95K.
  • Private Trust Company first reported a position in Genmab in Q2 2022 and held it in 15 quarters.
  • Private Trust Company's Genmab position peaked at $37K in Q4 2022.
  • 275 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Private Trust Company's 13F filing for Q1 2026, filed 30 Apr 2026.